A drug–drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors

Vincent A. de Weger, Sanjay Goel, Roger von Moos, Jan H.M. Schellens, Nicholas Mach, Eugene Tan, Suraj Anand, Jeffrey W. Scott, Ulrik Lassen

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'A drug–drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds